Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971857-24-000911
Filing Date
2024-12-30
Accepted
2024-12-30 16:32:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3508
  Complete submission text file 0001971857-24-000911.txt   4922
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
KAKKIS EMIL D (Reporting) CIK: 0001248093 (see all company filings)

Type: 144

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Subject) CIK: 0001515673 (see all company filings)

EIN.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36276 | Film No.: 241590233
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)